{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:17:55Z","timestamp":1777501075865,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ijantimicag.2021.106340","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T21:54:18Z","timestamp":1618955658000},"page":"106340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study"],"prefix":"10.1016","volume":"57","author":[{"given":"Sarah S.L.","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enqing","family":"Chee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn Q.","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej P.","family":"Chlebicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-4411","authenticated-orcid":false,"given":"Andrea L.H.","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2021.106340_bib0001","first-page":"165","article-title":"Vital Signs: Carbapenem-Resistant Enterobacteriaceae","volume":"62","year":"2013","journal-title":"MMWR"},{"key":"10.1016\/j.ijantimicag.2021.106340_bib0002","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cmi.2016.09.003","article-title":"Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States","volume":"23","author":"Bartsch","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2021.106340_bib0003","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2334-13-80","article-title":"A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection","volume":"13","author":"Correa","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106340_bib0004","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diagmicrobio.2012.11.009","article-title":"Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes","volume":"75","author":"van Duin","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106340_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00042-16","article-title":"Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia","volume":"30","author":"Hsu","year":"2017","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.ijantimicag.2021.106340_bib0006","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/cid\/ciaa065","article-title":"Languid uptake of ceftazidime-avibactam for carbapenem-resistant gram-negative infections and continued reliance on polymyxins","volume":"72","author":"Satlin","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ijantimicag.2021.106340_bib0007","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/522287","article-title":"A step closer to extreme drug resistance (XDR) in gram-negative bacilli","volume":"45","author":"Paterson","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106340_bib0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2021.106340_bib0009","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement","year":"2012"},{"issue":"12","key":"10.1016\/j.ijantimicag.2021.106340_bib0010","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1600-0463.2007.00722.x","article-title":"Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae","volume":"115","author":"Monstein","year":"2007","journal-title":"APMIS"},{"issue":"9","key":"10.1016\/j.ijantimicag.2021.106340_bib0011","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1128\/JCM.00661-08","article-title":"Rapid detection of blaKPC carbapenemase genes by real-time PCR","volume":"46","author":"Hindiyeh","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106340_bib0012","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/dkl481","article-title":"Multiplex PCR for rapid detection of genes encoding acquired metallo-b-lactamases","volume":"59","author":"Ellington","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2021.106340_bib0013","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.40.6.2153-2162.2002","article-title":"Detection of plasmid-mediated AmpC \u03b2-lactamase genes in clinical isolates by using multiplex PCR","volume":"40","author":"Perez-Perez","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2021.106340_bib0014","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajic.2011.05.022","article-title":"Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonised with carbapenem-resistant K. pneumoniae","volume":"40","author":"Borer","year":"2012","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2021.106340_bib0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1469-0691.2012.03888.x","article-title":"Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?","volume":"19","author":"Schechner","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.ijantimicag.2021.106340_bib0016","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1017\/S095026881700142X","article-title":"A hospital-based matched case-control study to identify risk factors for clinical infection with OXA-48-producing Klebsiella pneumoniae in rectal carriers","volume":"145","author":"Madue\u00f1o","year":"2017","journal-title":"Epidemiol Infect"},{"issue":"12","key":"10.1016\/j.ijantimicag.2021.106340_bib0017","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/1469-0691.12747","article-title":"Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study","volume":"20","author":"Giannella","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2021.106340_bib0018","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ijantimicag.2021.106340_bib0019","doi-asserted-by":"crossref","first-page":"e00261","DOI":"10.1128\/mSphere.00261-16","article-title":"Molecular epidemiology of colonising and infecting isolates of Klebsiella pneumoniae","volume":"1","author":"Martin","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.ijantimicag.2021.106340_bib0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/1469-0691.12577","article-title":"In vivo multiclonal transfer of blaKPC-3 from Klebsiella pneumoniae to Escherichia coli in surgery patients","volume":"20","author":"Gona","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.ijantimicag.2021.106340_bib0021","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/jac\/dkw221","article-title":"Natural history and decolonization strategies for ESBL\/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis","volume":"71","author":"Bar-Yoseph","year":"2016","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857921000820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857921000820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:38:03Z","timestamp":1760377083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857921000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0924857921000820"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106340","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106340"}}